Novalis Biotech aims for January second close for new €25m fund
Novalis Biotech Incubation, a Belgian seed-stage biotech investor, is fundraising for a second, €25m investment vehicle, according to co-founder and managing director Jan Van den Berghe.
More on Funds
TriSpan Opportunities Fund II holds first close
Fund focuses on investment opportunities in the lower-mid-market across North America and Europe
Andreessen Horowitz raises $4.5bn across two funds
VC raises $1.3bn for its seventh early-stage fund and $3.2bn for its second growth fund
HIG Europe Capital Partners III closes on €1.1bn
Fund invests in buyouts, recapitalisations and corporate carve-outs of European businesses
Latour Capital III holds final close on €1bn
Fund targets majority transactions and spin-outs of large companies mainly based in France
Latest News
Deutsche Beteiligungs AG announces supervisory board changes
Tom Alzin and Jannick Hunnecke will join, while Rolf Scheffels is to leave when his term ends
TriSpan Opportunities Fund II holds first close
Fund focuses on investment opportunities in the lower-mid-market across North America and Europe
Duff & Phelps appoints Bretag
Frank Bretag joins from Georgieff Capital Advisors and focuses on the industrial goods sector
Kartesia in €32m refinancing for Enterprise-backed Nu-Med
Enterprise Investors acquired a minority stake in the oncology company in 2013